NCT02840006

Brief Summary

CONTEXT: In patients eligible for coronary artery bypass surgery, anesthesia should provide a number of conditions that exceed the limits of cardiovascular stability, myocardial protection and other organs. Moreover, the combination of general anesthesia and spinal anesthesia lessens the homeostatic, metabolic, hormonal and immunosuppressive changes. The goal of this research was to evaluate the consumption of fentanyl citrate in intra-operative in Coronary Artery Bypass Grafting (CABG) surgery with cardiopulmonary bypass under spinal anesthesia associated with general anesthesia. METHODS: Clinical, prospective, randomized and double covered study, approved by the Research Ethics Committee. Fifty-six patients candidates for CABG with CPB, after signing the Terms of consent, were randomized and divided into two groups: GI - General and GII - General + subarachnoid. General anesthesia was induced according to the weight of each patient and maintenance with isoflurane and fentanyl. Spinal anesthesia was induced with 20 mg of 0.5% hyperbaric bupivacaine and 200 mcg of morphine, the patient is placed in cephalo-position slope of 45 degrees for 10 minutes in Group II. In the statistical study was performed using the Mann-Whitney test; the level of statistical significance was set at 5%.

Trial Health

80
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for phase_4

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2014

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2015

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

July 5, 2016

Completed
16 days until next milestone

First Posted

Study publicly available on registry

July 21, 2016

Completed
Last Updated

July 21, 2016

Status Verified

July 1, 2016

Enrollment Period

1 year

First QC Date

July 5, 2016

Last Update Submit

July 20, 2016

Conditions

Keywords

Vasoconstrictor AgentsVasodilator Agents

Outcome Measures

Primary Outcomes (1)

  • consumption of fentanyl citrate in intra-operative in Coronary Artery Bypass Grafting surgery with cardiopulmonary bypass under spinal anesthesia associated with general anesthesia.

    Will be measure the consumption of fentanyl in 24 hours

    in 24 hours

Study Arms (2)

General anesthesia only

ACTIVE COMPARATOR

Anesthetic induction with etomidate 0,3 a 0,4 mg.kg-1, citrate fentanyl 5 mcg.kg-1 and atracurium 0,5.kg-1

Procedure: General anesthesia only

General anesthesia associated spinal anesthesia

ACTIVE COMPARATOR

spinal anesthesia using bupivacaine 0,5% hyperbaric 20 mg, morphine 200 mcg, set trendeleburg for 10 minutes, sensitive test in T1. Anesthetic induction with etomidate 0,3 a 0,4 mg.kg-1, citrate fentanyl 5 mcg.kg-1 and atracurium 0,5.kg-1.

Procedure: General anesthesia and Spinal anesthesia

Interventions

Induction drugs: Citrate of fentanyl, atracurium, etomidate

General anesthesia only

Induction drugs: Citrate of fentanyl, atracurium, etomidate Spinal anesthesia: Bupivacaine hyperbaric, Morphine

General anesthesia associated spinal anesthesia

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients of both genders
  • Underwent cardiac artery bypass surgery with cardiopulmonary bypass, with
  • No restriction on age
  • No restriction on ethnicity
  • No restriction on education or social class

You may not qualify if:

  • Patients with sternotomy provided; those
  • Urgent surgery and/or emergency
  • Patient was with signs of shock
  • Patients with chronic renal failure
  • Patients with liver disorders
  • Tracheostomy patients
  • Patients with presence of use of mechanical ventilatory support;
  • Patients with physical disabilities; bedridden and wheelchair users.
  • Patients to withdraw the Consent and Informed
  • Patients who eventually had to be re-operated in the presence also of the mechanical ventilatory support.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Hospital das Clinicas Samuel Libânio

Pouso Alegre, Minas Gerais, 37550-000, Brazil

Location

Univas

Pouso Alegre, Minas Gerais, 37550-000, Brazil

Location

MeSH Terms

Interventions

Anesthesia, GeneralAnesthesia, Spinal

Intervention Hierarchy (Ancestors)

AnesthesiaAnesthesia and AnalgesiaAnesthesia, Conduction

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

July 5, 2016

First Posted

July 21, 2016

Study Start

September 1, 2014

Primary Completion

September 1, 2015

Last Updated

July 21, 2016

Record last verified: 2016-07

Data Sharing

IPD Sharing
Will share

Locations